Rating History for Rocket Pharmaceuticals (RCKT) by Goldman Sachs

More Stocks Rated by Goldman Sachs | Latest Ratings for RCKT
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
10/8/2026 Richard Law Upgrade Neutral
(Sell)		 4.00
(3.00)		 2.48
(2.18)		 -12.1% Details